We are monitoring the impact of COVID-19 on Europe Theranostics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 5760
Share on
Share on

Europe Theranostics Market Research Report - Segmented By Disease Type, Technology, End-User & Country(UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2020 to 2025)

Pulished: February, 2020
ID: 5760
Pages: 145

Europe Theranostics Market Size (2020 to 2025)

As per the research report, the size of the Theranostics market in Europe is estimated to grow at a healthy rate during the forecast period.

The increasing occurrence rate of cancer, technological advancements that are coming, growing awareness among the physicians about the particular disease are the major factors driving the European theranostics market during the forecast period. Increasing research and development towards the market and also promising FDA approvals may also stimulate the theranostics market growth during the period. The growing burden of chronic diseases and increasing collaborations and partnerships by critical players for developing companion diagnostics is considered to accelerate the market growth during the foreseen period.

The cost related to the maintenance and installation of the devices in the laboratories, the shortage of skilled physicians, strict rules, and regulations for the approval of the product launch is also hindering the market growth. Insufficient medical reimbursement policies among most of the economy developing countries are expected to limit the market growth during the period. Moreover, the high price of theranostics products is one-factor impeding market growth.

This research report segmented and sub-segmented into the following categories:

By Disease Type

  • Neurological Disorders
  • Cardiovascular Diseases
  • Immunological Disorders
  • Oncology
  • Others

By Technology

  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry
  • In Situ Hybridization
  • Sequencing
  • Others

By End-User

  • Hospitals
  • Diagnostics Laboratories
  • Others

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

The U.K. holds a significant share in the market due to the presence of market leaders as well as developed healthcare and pharmaceutical infrastructure. Germany is the fastest-growing region due to increasing expenditure on health care, product innovation, and rising disposable income. Based on Disease Type, Neurological disorders are the holding a significant share in the market due to the prevalence of diseases like Parkinson’s Disease, Alzheimer’s Disease, and other prevalent diseases, meanwhile, cancer diseases and cardiovascular disorders are expected to grow the fastest due to increasing risk rate and prevalence of these diseases and increasing research expenditure by pharmaceutical companies.

Key players operating in the Europe Theranostics Market profiled in this report are Abbott Laboratories, AmeriPath, Dickinson and Company, BIOTEC Laboratories, Dade Behring, Dianon Systems, Dynacare Laboratories, Enterix, Focus Diagnostics, Pfizer, and Beckman Coulter.

1. Introduction                                                                                 

                1.1 Market Definition                     

                1.2 Study Deliverables               

                1.3 Base Currency, Base Year and Forecast Periods        

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 Epidemology                                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1 Disease Type                                                                             

                                5.1.1 Introduction                                                           

                                5.1.2 Neurological Disorders                                                       

                                5.1.3 Cardiovascular Diseases                                                    

                                5.1.4 Cancers                                                    

                                5.1.5 Others                                                      

                                5.1.6  Y-o-Y Growth Analysis, By Disease Type                                                    

                                5.1.7  Market Attractiveness Analysis, By Disease Type                                                  

                                5.1.8  Market Share Analysis, By Disease Type                                                   

6. Geographical Analysis                                                                                              

                6.1 Introduction                                                                               

                                6.1.1 Regional Trends                                                    

                                6.1.2 Impact Analysis                                                     

                                6.1.3 Y-o-Y Growth Analysis                                                        

                                       By Geographical Area                                     

                                       By Disease Type                                

                                6.1.4  Market Attractiveness Analysis                                                     

                                       By Geographical Area                                     

                                       By Disease Type                                

                                6.1.5  Market Share Analysis                                                      

                                       By Geographical Area                                     

                                       By Disease Type                                

                6.2 U.K                                                                 

                6.3 Spain                                                                             

                6.4 Germany                                                                     

                6.5 Italy                                                                               

                6.6 France                                                                          

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 Abbott Laboratories                                                                               

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Financial analysis                                                  

                                8.1.4 Recent Developments                                                       

                                8.1.5 SWOT analysis                                                       

                                8.1.6 Analyst View                                                          

                8.2 AmeriPath                                                                  

                8.3 Dickinson and Company                                                                        

                8.4 BIOTEC Laboratories                                                                               

                8.5 Dade Behring                                                                             

                8.6 Dianon Systems                                                                        

                8.7 Dynacare Laboratories                                                                           

                8.8 Enterix                                                                          

                8.9 Focus Diagnostics                                                                     

                8.10 Pfizer                                                                          

9. Competitive Landscape                                                                                           

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10. Market Outlook and Investment Opportunities                                                                                         


                a) List of Tables                                                                

                b) List of Figures                                                                              

  • Europe and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Region, by Diseases along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market



  1. Europe Theranostics Market By Disease Type, From 2020 to 2025 (USD Billion)
  2. Europe Neurological Disorders Market By Region, From 2020 to 2025 (USD Billion)
  3. Europe Cardivascular Disorders Market By Region, From 2020 to 2025 (USD Billion)
  4. Europe Cancers Market By Region, From 2020 to 2025 (USD Billion)
  5. Europe Others Market By Region, From 2020 to 2025 (USD Billion)
  6. U.K. Theranostics Market By Disease Type, From 2020 to 2025 (USD Billion)
  7. Germany Theranostics Market By Disease Type, From 2020 to 2025 (USD Billion)
  8. France Theranostics Market By Disease Type, From 2020 to 2025 (USD Billion)
  9. Italy Theranostics Market By Disease Type, From 2020 to 2025 (USD Billion)
  10. Spain Theranostics Market By Disease Type, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample